29.47

7.92% 2.08

Hims Hers Health Inc (HIMS)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt HIMS? Forum Prognose

Schlusskurs vom Vortag:

$27.39

Offen:

$27.55

24-Stunden-Volumen:

9.97M

Relative Volume:

0.61

Marktkapitalisierung:

$6.88B

Einnahmen:

$2.35B

Nettoeinkommen (Verlust:

$128.37M

KGV:

56.45

EPS:

0.5221

Netto-Cashflow:

$57.42M

1W Leistung:

-1.37%

1M Leistung:

-9.99%

6M Leistung:

+86.85%

1J Leistung:

-29.92%

1-Tages-Spanne:

$27.41

$29.64

1-Wochen-Bereich:

$27.38

$30.10

52-Wochen-Spanne:

$13.74

$65.30

Hims Hers Health Inc Stock (HIMS) Company Profile

Firmenname

Hims Hers Health Inc

Sektor

Healthcare (1087)

Branche

Drug Manufacturers - Specialty & Generic (88)

Telefon

415-851-0195

Adresse

2269 CHESTNUT ST, SAN FRANCISCO

Mitarbeiter

2,442

Twitter

Nächster Verdiensttermin

2026-08-10

Neueste SEC-Einreichungen

HIMS's Discussions on Twitter

Compare HIMS vs TAK, TEVA, HLN, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
HIMS Hims Hers Health Inc	29.47	6.68B	2.35B	128.37M	57.42M	0.5221
TAK Takeda Pharmaceutical Co Adr	18.32	55.50B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	37.34	42.49B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.855	42.14B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	77.15	30.15B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	527.04	21.81B	3.17B	1.29B	1.01B	27.09

Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-24	Eingeleitet	JP Morgan	Overweight
2026-03-10	Hochstufung	BofA Securities	Underperform → Neutral
2026-03-10	Hochstufung	Citigroup	Sell → Neutral
2026-03-09	Hochstufung	Needham	Hold → Buy
2026-02-24	Herabstufung	BTIG Research	Buy → Neutral
2026-01-12	Eingeleitet	Evercore ISI	In-line
2025-12-09	Eingeleitet	Barclays	Overweight
2025-10-21	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2025-06-23	Herabstufung	Needham	Buy → Hold
2025-06-04	Bestätigt	Needham	Buy
2025-04-29	Herabstufung	TD Cowen	Buy → Hold
2025-02-18	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2025-01-10	Herabstufung	Citigroup	Neutral → Sell
2025-01-07	Eingeleitet	BTIG Research	Buy
2024-12-17	Eingeleitet	Morgan Stanley	Overweight
2024-11-14	Herabstufung	BofA Securities	Buy → Underperform
2024-08-22	Eingeleitet	Needham	Buy
2024-08-09	Herabstufung	Imperial Capital	Outperform → In-line
2024-05-22	Herabstufung	Citigroup	Buy → Neutral
2024-04-16	Herabstufung	Jefferies	Buy → Hold
2024-04-10	Eingeleitet	Canaccord Genuity	Buy
2024-02-28	Hochstufung	Imperial Capital	In-line → Outperform
2024-02-26	Eingeleitet	Leerink Partners	Market Perform
2023-12-07	Eingeleitet	Imperial Capital	In-line
2023-07-28	Eingeleitet	TD Cowen	Outperform
2023-04-11	Eingeleitet	Robert W. Baird	Neutral
2023-02-09	Hochstufung	Jefferies	Hold → Buy
2022-11-08	Hochstufung	BofA Securities	Neutral → Buy
2022-11-08	Hochstufung	SVB Leerink	Mkt Perform → Outperform
2022-10-17	Herabstufung	Piper Sandler	Overweight → Neutral
2022-09-07	Eingeleitet	Truist	Hold
2022-07-15	Eingeleitet	SVB Leerink	Underperform
2022-04-14	Eingeleitet	Guggenheim	Buy
2022-04-01	Fortgesetzt	Credit Suisse	Outperform
2022-03-10	Eingeleitet	Deutsche Bank	Hold
2021-12-02	Eingeleitet	Jefferies	Hold
2021-11-11	Hochstufung	Piper Sandler	Neutral → Overweight
2021-07-06	Eingeleitet	BofA Securities	Neutral
2021-05-20	Hochstufung	Credit Suisse	Neutral → Outperform
2021-04-21	Eingeleitet	Truist	Hold
2021-03-09	Eingeleitet	Credit Suisse	Neutral
2021-03-02	Hochstufung	Citigroup	Neutral → Buy
2021-02-17	Eingeleitet	Citigroup	Neutral
2021-02-12	Eingeleitet	Piper Sandler	Neutral
2021-02-08	Eingeleitet	Tigress Financial	Buy

Alle ansehen

Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten

12:32 PM

Hims & Hers Rejects Privacy Allegations While Promising Expanded Patient Access - Benzinga

12:32 PM

11:45 AM

Hims & Hers Health sees 17x international reven... - Pluang

11:45 AM

10:26 AM

Wellness Briefing: Hims & Hers plots rapid expansion into peptide therapies like BPC-157, plus news - glossy.co

10:26 AM

10:02 AM

Hims & Hers: Buying The Margin Dip (NYSE:HIMS) - Seeking Alpha

10:02 AM

09:07 AM

Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (HIMS) - marketscreener.com

09:07 AM

06:37 AM

Hims & Hers' Chief Accounting Officer Is Leaving. Here's What Her Latest Insider Filing Shows - The Motley Fool

06:37 AM

06:29 AM

An Insider at Hims & Hers Just Filed. Here's What It Says About Buying the Dip - The Motley Fool

06:29 AM

06:11 AM

A Hims & Hers Insider Disposed of Stock as the Company Pushes Into Testosterone and Peptides. Here's What to Know - The Motley Fool

06:11 AM

05:57 AM

An Insider at Hims & Hers Disposed of Over $3 Million in Stock. Here's What Long-Term Investors Should Know - The Motley Fool

05:57 AM

05:48 AM

The CTO of Hims & Hers Just Gave Up Nearly $2.7 Million in Stock. Here's What It Actually Means - The Motley Fool

05:48 AM

05:45 AM

What Long-Term Investors Should Know About This Hims Insider Filing - The Motley Fool

05:45 AM

05:38 AM

Hims & Hers' CEO Just Disposed of 78,859 Shares. Here's What Long-Term Investors Should Know. - The Motley Fool

05:38 AM

05:29 AM

An Insider at Hims & Hers Just Filed. Here's What It Says About Buying the Dip - The Motley Fool

05:29 AM

05:25 AM

Hims & Hers' Policy Chief Just Filed an Insider Transaction. Here's What It Means. - The Motley Fool

05:25 AM

01:38 AM

Companies with huge datasets can save up to 80% in AI costs by using open-weight models: Hims CEO - Business Insider

01:38 AM

Aug 18, 2026

Hims & Hers Health Boosts Revenue Target, Swings to Second-Quarter Loss - wsj.com

Aug 18, 2026

Oluyemi Okupe Sells 55,383 Shares of Hims & Hers Health (NYSE:HIMS) Stock - MarketBeat

Aug 18, 2026

Insider Selling: Hims & Hers Health (NYSE:HIMS) CFO Sells $261,831.32 in Stock - MarketBeat

Aug 18, 2026

Hims & Hers Health (NYSE: HIMS) Stock Plunges 14% Following - GlobeNewswire

Aug 18, 2026

Hims & Hers CEO Andrew Dudum Says AI Health Coach Could Be Just 12 Months Away, Believes It Could Increase Medication Adherence - Stocktwits

Aug 18, 2026

Kaplan Fox Announces an Investigation Into Hims & Hers Health, In - The National Law Review

Aug 18, 2026

Hims & Hers Health Options Spot-On: On August 18th, 65,547 Contracts Were Traded, With 886.89K Open Interest - moomoo.com

Aug 18, 2026

HIMS Looks 34.0% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus

Aug 18, 2026

Hims CEO responds to FTC suit, sees GLP-1 prices falling to $40-$50: CNBC - Seeking Alpha

Aug 18, 2026

Hims & Hers CEO Andrew Dudum pushes back on FTC lawsuit - qz.com

Aug 18, 2026

Hims & Hers CEO pushes back against FTC suit, says "we are active disruptors" - Investing.com Nigeria

Aug 18, 2026

Hims & Hers CEO Tells the FTC That Regulators Just Don’t Understand - Yahoo Finance

Aug 18, 2026

Hims & Hers CEO says FTC lawsuit misunderstands how the company works - CNBC

Aug 18, 2026

Hims & Hers: Eucalyptus Deal Unlocks New Markets (NYSE:HIMS) - Seeking Alpha

Aug 18, 2026

Hims & Hers Health Stock Short Interest Rises to 32.05% - Quiver Quantitative

Aug 18, 2026

Aug 17, 2026

HIMS Stock Has Quadrupled In 5 Years: How Hims Turned A $3 Stock Into A Telehealth Giant - Stocktwits

Aug 17, 2026

Hims & Hers Stock (HIMS) Opinions on Five-Year Public Listing Anniversary - Quiver Quantitative

Aug 17, 2026

Financial Markets Wall Street - Dayton Daily News

Aug 17, 2026

Kaplan Fox Alerts Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to Possible Securities Law Violations - The National Law Review

Aug 17, 2026

HIMS Stock Snaps 2-Day Climb: Analyst Says Record Subscriber Growth ‘Not Enough’ To Offset Margin Slide - Stocktwits

Aug 17, 2026

5 Revealing Analyst Questions From Hims & Hers Health’s Q2 Earnings Call - Yahoo Finance

Aug 17, 2026

Aug 16, 2026

HIMS Stock Climbs Overnight: Oscar Health CEO Courts Hims For New Drug Marketplace - Stocktwits

Aug 16, 2026

Aug 15, 2026

Citi Says Hims & Hers’ Full-Year Outlook Indicates ‘Hefty’ Q4 Earnings Lift, Warns Of Execution Risks - Stocktwits

Aug 15, 2026

Hims & Hers Health (NYSE:HIMS) Upgraded to Hold at Wall Street Zen - MarketBeat

Aug 15, 2026

Aug 14, 2026

Hims & Hers Health, Inc. • Robinhood Token Price, HIMS Price, Live Charts, and Marketcap - Coinbase

Aug 14, 2026

Hims & Hers Health CTO Mohamed Elshenawy Awarded 1.2 Million RSUs - Kalkine Media

Aug 14, 2026

Hims & Hers Health Director Christopher D. Payne Awarded 8,768 RSUs in August 2026 - Kalkine Media

Aug 14, 2026

Hims & Hers (HIMS) Raised Guidance. Can Growth Survive Its GLP-1 Margin Reset? - Yahoo Finance

Aug 14, 2026

Hims & Hers Health raises 2023 revenue outlook after strong Q2 growth despite margin drop - pluang.com

Aug 14, 2026

Hims & Hers Health's Next Act: Making Its Own Drugs Again (NYSE:HIMS) - Seeking Alpha

Aug 14, 2026

Investor relations - HIMS investor relations

Aug 14, 2026

Aug 13, 2026

Kaplan Fox Reminds Investors of Hims & Hers Health, Inc. (NYSE: H - The National Law Review

Aug 13, 2026